NM_016379.4:c.493A>G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_016379.4(VCX3A):c.493A>G(p.Ser165Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016379.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 18
GnomAD4 exome Data not reliable, filtered out with message: AC0;AS_VQSR AF: 0.00 AC: 0AN: 1030380Hom.: 0 Cov.: 42 AF XY: 0.00 AC XY: 0AN XY: 340072
GnomAD4 genome Cov.: 18
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.493A>G (p.S165G) alteration is located in exon 3 (coding exon 2) of the VCX3A gene. This alteration results from a A to G substitution at nucleotide position 493, causing the serine (S) at amino acid position 165 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at